These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30964246)

  • 21. Prevention and control of jet lag symptoms and temporary impairment of cognitive function with Pycnogenol® in healthy individuals and in hypertensives.
    Belcaro G; Hu S; Hosoi M; Cesarone MR; Ledda A; Dugall M; Cornelli U; Saggino A; Cotellese R; Feragalli B; Cox D; Peterzan P; Scipione C; Scipione V
    Minerva Med; 2024 Apr; 115(2):178-184. PubMed ID: 38197571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary benign back pain: supplementation with Pycnogenol®.
    Cox D; Belcaro G; Cesarone MR; Cotellese R; Dugall M; Feragalli B; Hosoi M; Corsi M; Luzzi R
    Panminerva Med; 2021 Dec; 63(4):472-477. PubMed ID: 34915691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive effects of Pycnogenol®-Centellicum® on venous elasticity: an ex-vivo concept study.
    Belcaro G; Dugall M; Hosoi M; Ippolito E; Cesarone MR; Cox D; Scipione C; Scipione V; Cornelli U; Corsi M; Feragalli B; Cotellese R
    Minerva Surg; 2023 Dec; 78(6):651-656. PubMed ID: 37534931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
    Yoon Y; Shim WH; Lee DH; Pyun WB; Kim IJ; Jang Y; Cho SY
    Am J Cardiol; 1999 Dec; 84(12):1375-80. PubMed ID: 10606107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antiplatelet therapy after aspirin-induced upper gastrointestinal bleeding].
    Johansen M
    Tidsskr Nor Laegeforen; 2006 Nov; 126(21):2802-4. PubMed ID: 17086221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xerostomia and prevention of dryness with a Pycnogenol® mouth spray: a pilot study.
    Cesarone MR; Belcaro G; Scipione C; Scipione V; Dugall M; Hu S; Feragalli B; Cotellese R
    Minerva Gastroenterol (Torino); 2024 Mar; 70(1):36-41. PubMed ID: 37162467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventive effects of Pycnogenol® on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19).
    Belcaro G; Cornelli U; Cesarone MR; Scipione C; Scipione V; Hu S; Feragalli B; Corsi M; Cox D; Cotellese R; Hosoi M; Burki C
    Minerva Med; 2022 Apr; 113(2):300-308. PubMed ID: 34060731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xerostomia: prevention with Pycnogenol® supplementation: a pilot study.
    Belcaro G; Cesarone MR; Cornelli U; Scipione C; Scipione V; Dugall M; Hu S; Feragalli B; Hosoi M; Maione C; Cotellese R; Cesinaro Di Rocco P
    Minerva Stomatol; 2019 Dec; 68(6):303-307. PubMed ID: 32052619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of only 2 weeks of ticlopidine therapy in patients at increased risk of coronary stent thrombosis: results from the Antiplatelet Therapy alone versus Lovenox plus Antiplatelet therapy in patients at increased risk of Stent Thrombosis (ATLAST) trial.
    Berger PB; Mahaffey KW; Meier SJ; Buller CE; Batchelor W; Fry ET; Zidar JP;
    Am Heart J; 2002 May; 143(5):841-6. PubMed ID: 12040346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation.
    Moussa I; Oetgen M; Roubin G; Colombo A; Wang X; Iyer S; Maida R; Collins M; Kreps E; Moses JW
    Circulation; 1999 May; 99(18):2364-6. PubMed ID: 10318654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pycnogenol® supplementation prevents inflammation and symptoms in recurrent, non-severe urinary infections.
    Cotellese R; Hu S; Cesarone MR; Belcaro G; Dugall M; Feragalli B; Hosoi M; Ippolito E; Corsi M; Luzzi R
    Panminerva Med; 2021 Sep; 63(3):343-348. PubMed ID: 34738775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pycnogenol® supplementation in minimal cognitive dysfunction.
    Hosoi M; Belcaro G; Saggino A; Luzzi R; Dugall M; Feragalli B
    J Neurosurg Sci; 2018 Jun; 62(3):279-284. PubMed ID: 29754480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic venous insufficiency and venous microangiopathy: management with compression and Pycnogenol®.
    Cesarone MR; Belcaro G; Agus GB; Ippolito E; Dugall M; Hosoi M; Corsi M; Cotellese R; Feragalli B; Scipione C; Scipione V; Maione C
    Minerva Cardioangiol; 2019 Aug; 67(4):280-287. PubMed ID: 31347820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study.
    Errichi BM; Belcaro G; Hosoi M; Cesarone MR; Dugall M; Feragalli B; Bavera P; Hosoi M; Zulli C; Corsi M; Ledda A; Luzzi R; Ricci A
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):21-7. PubMed ID: 22108473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
    Wallén H; Agren A; Nekludov M
    Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol®.
    Hu S; Hosoi M; Belcaro G; Dugall M; Feragalli B; Cotellese R; Luzzi R
    Minerva Cardioangiol; 2019 Oct; 67(5):392-398. PubMed ID: 31637898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses].
    Iturbe T; Sánchez C; Moreno JA; Olave T; Azaceta G; Varo MJ; Civeira E; Peleato J; Cornudella R
    Sangre (Barc); 1997 Oct; 42(5):387-90. PubMed ID: 9424739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recommendations for peri-procedural thrombocyte aggregation inhibition].
    Sauer H; Leschke M
    Dtsch Med Wochenschr; 2006 Feb; 131(8):400-2. PubMed ID: 16479474
    [No Abstract]   [Full Text] [Related]  

  • 40. Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment.
    Cesarone MR; Belcaro G; Hosoi M; Ledda A; Feragalli B; Maione C; Scipione C; Scipione V; Cotellese R; Hu S
    J Neurosurg Sci; 2020 Jun; 64(3):258-262. PubMed ID: 31957998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.